NFG
NVCT icon

Nations Financial Group’s Nuvectis Pharma NVCT Stock Holding History

Nations Financial Group’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$100K Hold
13,000
– – 0.01% 761
2025
Q4 		$98.2K Hold
13,000
– – 0.01% 739
2025
Q3 		$78.3K Hold
13,000
– – ﹤0.01% 703
2025
Q2 		$97.1K Sell
13,000
-500
-4% -$4.53K 0.01% 672
2025
Q1 		$132K Hold
13,500
– – 0.01% 639
2024
Q4 		$73K Buy
13,500
+3,500
+35% +$21.9K 0.01% 657
2024
Q3 		$62.9K Buy
+10,000
New +$65.8K ﹤0.01% 663

Other funds holding NVCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Nations Financial Group's NVCT Position: Q1 2026 in Review

Nations Financial Group held its Nuvectis Pharma (NVCT) position steady in Q1 2026 at 13,000 shares worth $100K. The position accounts for 0.01% of the portfolio, ranked #761.

Nations Financial Group first reported a position in NVCT in Q3 2024 and has held it in 7 quarters since. The position peaked at $132K in Q1 2025. 62 funds tracked by Wall St. Rank hold NVCT as of Q1 2026.

  • Nations Financial Group held 13,000 shares of Nuvectis Pharma worth $100K as of Q1 2026.
  • Nations Financial Group left its Nuvectis Pharma share count unchanged in Q1 2026.
  • Nuvectis Pharma made up 0.01% of Nations Financial Group's portfolio in Q1 2026, its #761 holding.
  • Nations Financial Group first reported a position in Nuvectis Pharma in Q3 2024 and has held it in 7 quarters since.
  • Nations Financial Group's Nuvectis Pharma position peaked at $132K in Q1 2025.
  • 62 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q1 2026.

Based on Nations Financial Group's 13F filing for Q1 2026, filed 15 Apr 2026.